In AD and PD, THRs help regulate amyloid precursor protein (APP) processing via GSK-3β and reduce toxic Aβ plaque accumulation, while in PD, THRs support dopamine synthesis through the regulation of tyrosine hydroxylase [176]. This evidence concerns the gene GSK3B and Parkinson disease.